Miltenyi Biotec
Miltenyi Biotec home - back to start page
Home ¦ Contact ¦ Ordering ¦ Terms & conditions ¦ Legal notes ¦ Jobs ¦ Forum ¦ Business development ¦ Sitemap
Miltenyi Biotec home - back to start page
Miltenyi Biotec home - back to start page
Miltenyi Biotec
MACS® Cell SeparationMiltenyi BiotecMACS® Cell AnalysisMiltenyi BiotecMACS® Cell CultureMiltenyi BiotecMACSmolecularMiltenyi BiotecClinical ProductsMiltenyi BiotecIndustrial ServicesMiltenyi BiotecMiltenyi BiotecCustomer supportMiltenyi BiotecCompany

Miltenyi Biotec
Baxter products
MACS Cytokines and Growth Factors
MACSĀ® Tools for neuroscience research
Tregs—the complete portfolio
Comprehensive Genomics Services, just send your samples…
MACS eNewsletter
Subscribe to the
MACS eNewsletter
for regular product information via e-mail.
Miltenyi Biotec
Display technology
Introduction to display technology
What is display technology?
Display technology classically involves the screening of a large library of expressed proteins using an immobilized ligand to characterize or discover new protein-protein interactions.

Characteristics of display technology
The key to rapid discovery and characterization of protein-ligand interactions is the ability to couple the proteins being screened (phenotype) with the genetic information encoding them (genotype).
In spite of the huge advances in protein sequencing methods in recent years, it is faster and more convenient if the genetic information of a ligand is isolated simultaneously with the protein of interest. This is the most important characteristic of display technology. In addition, a large library of proteins must be generated and displayed to the ligand of interest. The larger the library, the greater is the chance of finding a binding partner.
The third important factor is that it must be possible to amplify this library without introducing a bias for a particular type of DNA fragment/protein to enable successive unbiased rounds of screening against a particular ligand.
A further attractive feature of a display system is the ability to introduce errors randomly into the encoding DNA sequence to isolate mutant proteins with altered binding affinities or binding kinetics (SELEX technology; affinity maturation).

Uses of display technology
  • Discovery of new ligands
  • Characterization of protein-ligand interactions
  • Affinity maturation of protein-ligand interactions
There are a number of popular display technologies based on display of proteins or protein fragments on the surface of biological entities, for examples, phage display, yeast display, which rely on the replication of the organism to amplify the library and introduce errors.
As an alternative to these in vivo systems, there is also the possibility to carry out the whole process in a tube. In this case in vitro-generated transcripts are translated in cell extracts and reverse transcription (RT)-PCR is used to amplify the genetic information after the ligand-mediated isolation of mRNA-ribosome-protein complexes has taken place (ribosome display).

Display technologies with MACSĀ® Products
In all of these systems, magnetic sorting with MACS Technology enables an efficient and rapid isolation of interacting proteins.

Library proteins interacting with labeled, for example, biotinylated, ligands can be isolated using Streptavidin or Anti-Biotin MicroBeads as shown in figure 1. If the ligand is an antibody, μMACS Protein A or Proterin G MicroBeads can be used.

For sorting of cell-surface expressed libraries
- Anti-Biotin MicroBeads
- Streptavidin MicroBeads

For sorting of molecular and phage libraries
- µMACS Protein A MicroBeads
- µMACS Protein G MicroBeads
- µMACS Streptavidin Kit
Display technology and magnetic sorting
Advantages of magnetic sorting
  • Large scale screening - orders of magnitude more events can be sorted compared to FACS
  • Rapid magnetic isolation - sorting in a matter of minutes instead of days
  • Convenient - no trained operator required
  • Effective - very low non-specific enrichment compared to conventional panning techniques due to highly efficient wash steps

Phage display
1011 bacteriophage particles can be sorted in one μ Column3 to
  • Identify and analyse features of surface proteins that interact with other proteins
  • Isolate new ligands that bind to particular amino acid sequences
  • Improve the affinity and specificity of the interaction between ligands and their target structures
Starting protocol using a biotinylated target (for example protein) and μMACSā„¢ Streptavidin MicroBeads, available at www.miltenyibiotec.com.

Yeast display
Yeast display: 1010 yeast cells can be sorted in one LS Column2,6 or using the autoMACSā„¢ Separator6 for:
  • Correct post-translational modification, processing and folding of mammalian proteins
  • Inducible expression allowing a 1010-fold expansion of a library without biased selection
  • Rapid characterization of binding affinities of interacting proteins
  • Protocol developed by Prof. Dane Wittrup of the Massachussetts Institute of Technology1
  • Full protocol available at http://www.sysbio.org/dataresources/singlechain.stm and Chao et al.6

Ribosome display
Ribosome display: 1013 ribosome-mRNA complexes can be sorted in one μ Column4,5 to
  • Select large protein libraries in vitro Amplify isolated RNAs by RT-PCR
Further information
µMACSā„¢ Streptavidin Kit—phage display
[PDF; 53,2 KB]
 
Figure 1
General working scheme for screening a library for ligand-binding activity using display technology with MACSĀ® Technology.
Figure 2
Magnetic labeling of a yeast display library using MACSĀ® Technology.
(Adapted from Feldhaus et al. 2003 Nat. Biotech. 21: 163-170)
Miltenyi Biotec
Customer login
Customer login
Forgot your password?
New customer?
Get more information
My favorites
Your current favorite list is empty.
Products
Anti-Biotin MicroBeads
for 109 total cells
Download data sheet
130-090-485
Qty:
 

Streptavidin MicroBeads
for 109 total cells
Download data sheet
130-048-102
Qty:
 

for 2Ɨ109 total cells
Download data sheet
130-048-101
Qty:
 

μMACS Protein A MicroBeads
for 20-40 immunopurifications
Components:
- 2 mL
Download data sheet
130-071-001
Qty:
 

μMACS Protein G MicroBeads
for 20-40 immunopurifications
Components:
- 2 mL
Download data sheet
130-071-101
Qty:
 

μMACS Protein A/G Starting Kit
for 20-40 immunopurifications
Components:
- 1 μMACS Separator
- 20 μ Columns
- 1 MACS MultiStand
- 2 mL μMACS Protein A or 2 mL μMACS Protein G MicroBeads
130-042-601
Qty:
 

μMACS Streptavidin Kit
For research use only
for 20 isolations
Components:
- 2 mL μMACS Streptavidin MicroBeads
- 4 mL Equilibration Buffer for nucleic acids applications
- 4 mL Equilibration Buffer for protein applications
- 20 μ Columns
Download data sheet
130-074-101
Qty:
 

μMACS Streptavidin Starting Kit
For research use only
for 20 isolations
Components:
- 1 μMACS Streptavidin Kit
- 1 μMACS Separator
- 1 MACS MultiStand
130-091-287
Qty:
 

MACS References
1. Boder and Wittrup (1997) Nat Biotechnol. 15: 553-7.[8503]
2. Feldhaus et al. (2003) Nat Biotechnol. 21: 163-70.[2970]
3. Siegel et al. (1997) J Immunol Methods 206: 73-85.[884]
4. Schaffitzel et al. (1999) J Immunol Methods 231: 119-135.[8505]
5. Weichhart et al. (2003) Infect Immun. 71: 4633-41.[3085]
6. Chao et al. (2006) Nat. Protoc. 1: 755-768[10467]
Miltenyi Biotec
Miltenyi Biotec
© 1999 - 2008 Miltenyi Biotec
Miltenyi Biotec